bioAffinity Technologies (BIAF) Accounts Payables (2021 - 2026)
bioAffinity Technologies (BIAF) reported Accounts Payables of $836211.0 for Q1 2026, down 39.47% year-over-year from $1.4 million in Q1 2025, and up 9.75% quarter-over-quarter from $761901.0 in Q4 2025.
bioAffinity Technologies (BIAF) Accounts Payables (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Accounts Payables data on file, last reported at $836211.0 in Q1 2026.
- Accounts Payables for Q1 2026 came in at $836211.0, down 39.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $836211.0 (down 39.47% YoY), and the FY2025 annual result was $761901.0, down 22.83% from the prior year.
- Accounts Payables climbed to $836211.0 in Q1 2026 per BIAF's latest filing, from $761901.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $1.4 million in Q1 2025 and troughed at $146537.0 in Q1 2023.
- A 5-year average of $689378.5 and a median of $782937.0 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2026: Accounts Payables jumped 452.09% in 2023, then sank 39.47% in 2026.
- A 5-year view of Accounts Payables shows it stood at $345042.0 in 2022, then soared by 75.28% to $604789.0 in 2023, then jumped by 63.25% to $987311.0 in 2024, then decreased by 22.83% to $761901.0 in 2025, then grew by 9.75% to $836211.0 in 2026.
- Business Quant data shows BIAF's Accounts Payables at $836211.0 in Q1 2026, $761901.0 in Q4 2025, and $940761.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 602.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 3.34 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.79 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 129.97 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 615.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 62.40 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.64 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 218.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 228.72 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | 836,211.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 836,211.00 |
| Dec 31, 2025 | 761,901.00 |
| Sep 30, 2025 | 940,761.00 |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 987,311.00 |
| Sep 30, 2024 | 782,937.00 |
| Jun 30, 2024 | 848,102.00 |
| Mar 31, 2024 | 383,993.00 |
| Dec 31, 2023 | 604,789.00 |
| Sep 30, 2023 | 827,407.00 |
| Jun 30, 2023 | 174,404.00 |
| Mar 31, 2023 | 146,537.00 |
| Dec 31, 2022 | 345,042.00 |
| Sep 30, 2022 | 149,867.00 |
| Dec 31, 2021 | 230,407.00 |